Suchergebnisse - "Protein Kinase Inhibitors"

PubPharm (61.514)

1

Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations : Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

enthalten in: JCO precision oncology | 2024

von Chen, M. | Song, Z. | Yu, H. | +19

2

Exploring Novel 1-Hydroxynaphthalene-2-Carboxanilides Based Inhibitors Against C-Jun N-Terminal Kinases Through Molecular Dynamic Simulation and WaterSwap Analysis

enthalten in: Applied biochemistry and biotechnology | 2024

von Jamal, S. | Ismail, S. | Yousaf, R. | +3

ErratumIn: Appl Biochem Biotechnol. 2023 Sep 16;:. - PMID 37715895

3

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours

enthalten in: British journal of cancer | 2024

von Burris, H. | Berlin, J. | Arkenau, T. | +9

4

A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia : making progress in chemotherapy-free regimens

enthalten in: Hematology (Amsterdam, Netherlands) | 2024

von Xiong, Z. | Shen, Y. | Zhang, S. | +1

5

Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

enthalten in: Leukemia & lymphoma | 2024

von Lionel, A. | Gurumurthi, A. | Fetooh, A. | +13

6

Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer

enthalten in: Cancer letters | 2024

von Han, R. | Lin, C. | Lu, C. | +10

7

SAFE-ROCK : A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

enthalten in: CNS drugs | 2024

von Wolff, A. | Peine, J. | Höfler, J. | +3

8

Combining forces for good : chimeric antigen receptor T-cells and Bruton tyrosine kinase inhibitors in mantle cell lymphoma with central nervous system involvement

enthalten in: Leukemia & lymphoma | 2024

von Minson, A. | Dickinson, M.

ErratumIn: Leuk Lymphoma. 2024 Apr 12;:1. - PMID 38606813

9

Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer : A prospective study

enthalten in: Thoracic cancer | 2024

von Wu, Y. | Mo, H. | Xu, H. | +4

10

Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib : A Report of 2 Cases

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von Schubert, C. | Schiffmann, I. | Farschtschi, S. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[6152]